Lavinia Fabeni

1.5k total citations
58 papers, 599 citations indexed

About

Lavinia Fabeni is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Lavinia Fabeni has authored 58 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Infectious Diseases, 33 papers in Virology and 17 papers in Epidemiology. Recurrent topics in Lavinia Fabeni's work include HIV Research and Treatment (32 papers), HIV/AIDS drug development and treatment (28 papers) and HIV/AIDS Research and Interventions (17 papers). Lavinia Fabeni is often cited by papers focused on HIV Research and Treatment (32 papers), HIV/AIDS drug development and treatment (28 papers) and HIV/AIDS Research and Interventions (17 papers). Lavinia Fabeni collaborates with scholars based in Italy, Cameroon and United States. Lavinia Fabeni's co-authors include Carlo Federico Perno, Francesca Ceccherini‐Silberstein, Andrea Antinori, Maria Mercedes Santoro, Daniele Armenia, Valentina Svicher, Marco Ciotti, Pierpaolo Paba, Massimo Andreoni and Federica Forbici and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and PLoS ONE.

In The Last Decade

Lavinia Fabeni

54 papers receiving 594 citations

Peers

Countries citing papers authored by Lavinia Fabeni

Since Specialization

Citations

This map shows the geographic impact of Lavinia Fabeni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lavinia Fabeni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lavinia Fabeni more than expected).

Fields of papers citing papers by Lavinia Fabeni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lavinia Fabeni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lavinia Fabeni. The network helps show where Lavinia Fabeni may publish in the future.

Co-authorship network of co-authors of Lavinia Fabeni

This figure shows the co-authorship network connecting the top 25 collaborators of Lavinia Fabeni. A scholar is included among the top collaborators of Lavinia Fabeni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lavinia Fabeni. Lavinia Fabeni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cerebrospinal Fluid and Peripheral Blood Lymphomonocyte Single-Cell Transcriptomics in a Subject with Multiple Sclerosis Acutely Infected with HIV 2024 ·International Journal of Molecular Sciences ·Carmela Pinnetti, Gabriella Rozera, Francesco Messina, Pietro Giorgio Spezia, (unknown), Lavinia Fabeni, Giovanni Chillemi, Daniele Pietrucci, Shalom Haggiag, Ilaria Mastrorosa, Alessandra Vergori, Enrico Girardi, Andrea Antinori, Fabrizio Maggi, Isabella Abbate	3
2	Molnupiravir increases SARS‐CoV‐2 genome diversity and complexity: A case‐control cohort study 2024 ·Journal of Medical Virology ·Cesare Ernesto Maria Gruber, (unknown), Emanuela Giombini, Valentina Mazzotta, Pietro Giorgio Spezia, Martina Rueca, Ilaria Mastrorosa, Lavinia Fabeni, Giulia Berno, Ornella Butera, (unknown), (unknown), Fabrizio Carletti, Daniele Focosi, Emanuele Nicastri, Enrico Girardi, Andrea Antinori, Fabrizio Maggi	2
3	Molecular Genotyping of Circulating Enterovirus in the Lazio Region from 2012 to 2023 2024 ·Viruses ·Martina Rueca, Francesco Vairo, Martina Spaziante, Lavinia Fabeni, Federica Forbici, Giulia Berno, Cesare Ernesto Maria Gruber, Simonetta Picone, Camilla Ajassa, Enrico Girardi, Fabrizio Maggi, Maria Beatrice Valli	0
4	Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals 2023 ·Journal of Clinical Virology ·Daniele Armenia, Roberta Gagliardini, Claudia Alteri, Valentina Svicher, Valeria Cento, Vanni Borghi, Alessandra Vergori, Stefania Cicalini, Federica Forbici, Lavinia Fabeni, Ada Bertoli, (unknown), William Gennari, Vincenzo Malagnino, Massimo Andreoni, Cristina Mussini, Andrea Antinori, Carlo Federico Perno, Maria Mercedes Santoro, Francesca Ceccherini‐Silberstein	4
5	Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant 2023 ·International Journal of Molecular Sciences ·Licia Bordi, Giuseppe Sberna, Eleonora Lalle, Lavinia Fabeni, Valentina Mazzotta, Simone Lanini, Angela Corpolongo, Anna Rosa Garbuglia, Emanuele Nicastri, Enrico Girardi, Francesco Vaia, Andrea Antinori, Fabrizio Maggi	4
6	Detection of SARS-CoV-2 Variants via Different Diagnostics Assays Based on Single-Nucleotide Polymorphism Analysis 2023 ·Diagnostics ·(unknown), Giulia Matusali, Fabrizio Carletti, Cesare Ernesto Maria Gruber, Lavinia Fabeni, Claudia Minosse, Emanuela Giombini, Martina Rueca, Fabrizio Maggi, Alessandra Amendola, Anna Rosa Garbuglia	6
7	Treatment-Emergent Cilgavimab Resistance Was Uncommon in Vaccinated Omicron BA.4/5 Outpatients 2023 ·Biomolecules ·Cesare Ernesto Maria Gruber, (unknown), Martina Rueca, Valentina Mazzotta, Giulia Gramigna, Alessandra Vergori, Lavinia Fabeni, Giulia Berno, Emanuela Giombini, Ornella Butera, Daniele Focosi, Ingrid G. Prandi, Giovanni Chillemi, Emanuele Nicastri, Francesco Vaia, Enrico Girardi, Andrea Antinori, Fabrizio Maggi	1
8	HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: A systematic review and meta-analysis 2022 ·SHILAP Revista de lepidopterología ·(unknown), Maria Mercedes Santoro, (unknown), Aude Christelle Ka’e, Yagaï Bouba, Alex Durand Nka, (unknown), Désiré Takou, (unknown), Lavinia Fabeni, Vittorio Colizzi, Carlo Federico Perno, Francesca Ceccherini‐Silberstein, Joseph Fokam	10
9	SARS-CoV-2 Variants Identification: Overview of Molecular Existing Methods 2022 ·Pathogens ·Giulia Berno, Lavinia Fabeni, Giulia Matusali, Cesare Ernesto Maria Gruber, Martina Rueca, Emanuela Giombini, Anna Rosa Garbuglia	19
10	Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy 2021 ·Journal of Hospital Infection ·Walter Mazzucco, Velia Chiara Di Maio, F. Bronte, Lavinia Fabeni, Rosaria Maria Pipitone, Stefania Grimaudo, Donatella Ferraro, Claudia Marotta, M. Aragri, Maurizio Macaluso, Francesco Vitale, Francesco Di Raimondo, Francesca Ceccherini‐Silberstein, V. Di Marco	5
11	Evaluation of HIV Transmission Clusters among Natives and Foreigners Living in Italy 2020 ·Viruses ·Lavinia Fabeni, Maria Mercedes Santoro, Patrizia Lorenzini, Stefano Rusconi, Nicola Gianotti, Andrea Costantini, Loredana Sarmati, Andrea Antinori, Francesca Ceccherini‐Silberstein, Antonella d’Arminio Monforte, Annalisa Saracino, Enrico Girardi	6
12	Lower prevalence of Blastocystis sp. infections in HIV positive compared to HIV negative adults in Ghana 2019 ·PLoS ONE ·Veronica Di Cristanziano, (unknown), Federica Berrilli, Fred Stephen Sarfo, (unknown), Lavinia Fabeni, Elena Knops, Eva Heger, Rolf Kaiser, Albert Dompreh, Richard Odame Phillips, Betty Norman, Torsten Feldt, Kirsten Alexandra Eberhardt	28
13	Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA 2016 ·Journal of Clinical Virology ·Mauro Zaccarelli, Maria Mercedes Santoro, Daniele Armenia, Vanni Borghi, William Gennari, Caterina Gori, Federica Forbici, Ada Bertoli, Lavinia Fabeni, Alberto Giannetti, Stefania Cicalini, Rita Bellagamba, Massimo Andreoni, Claudio Maria Mastroianni, Cristina Mussini, Francesca Ceccherini‐Silberstein, Carlo Federico Perno, Andrea Antinori	28
14	A recent epidemiological cluster of acute hepatitis B genotype F1b infection in a restricted geographical area of Italy 2015 ·Clinical Microbiology and Infection ·Michela Pollicita, Claudia Alteri, Maria Concetta Bellocchi, Daniele Armenia, Luca Carioti, Romina Salpini, Luna Colagrossi, (unknown), M. Aragri, Lavinia Fabeni, (unknown), Margherita D’Alessandro, (unknown), M. Paoloni, Giustino Parruti, Carlo Federico Perno, Valentina Svicher	4
15	Comparative replication capacity of raltegravir-resistant strains and antiviral activity of the new-generation integrase inhibitor dolutegravir in human primary macrophages and lymphocytes 2014 ·Journal of Antimicrobial Chemotherapy ·Michela Pollicita, Matteo Surdo, (unknown), (unknown), Lavinia Fabeni, Valentina Fedele, Isabelle Malet, Anne‐Geneviève Marcelin, Vincent Cálvez, Francesca Ceccherini‐Silberstein, Carlo Federico Perno, Valentina Svicher	19
16	The Genotypic False Positive Rate Determined by V3 Population Sequencing Can Predict the Burden of HIV-1 CXCR4-using Species Detected by Pyrosequencing 2013 ·PLoS ONE ·Valentina Svicher, Valeria Cento, Gabriella Rozera, Isabella Abbate, Maria Mercedes Santoro, Daniele Armenia, Lavinia Fabeni, Alessandro Bruselles, Alessandra Latini, Guido Palamara, Valeria Micheli, Giuliano Rizzardini, Caterina Gori, Federica Forbici, Giuseppe Ippolito, Massimo Andreoni, Andrea Antinori, Francesca Ceccherini‐Silberstein, Maria Rosaria Capobianchi, Carlo Federico Perno	10
17	Impact of baseline HIV-1 integrase polymorphisms on virological outcome in a large European cohort of patients starting a raltegravir-containing regimen 2011 ·Antiviral Therapy ·Daniele Armenia, Isabelle Malet, Lavinia Fabeni, Sandrine Reigadas, (unknown), David Dunn, Rolf Kaiser, Maurizio Zazzi, Kristel Van Laethem, Anna Artese, Carmen Garrido, Bernard Masquelier, (unknown), (unknown), Andrea Antinori, Anne‐Geneviève Marcelin, Carlo Federico Perno, Anna María Geretti, Francesca Ceccherini‐Silberstein	1
18	Signature mutations in V3 and bridging sheet domain of HIV-1 gp120 are specifically associated with dual tropism and modulate the interaction with CCR5 N-terminus 2011 ·Nano Letters ·Claudia Alteri, Anna Artese, (unknown), (unknown), Giosuè Costa, (unknown), Lavinia Fabeni, Ada Bertoli, Federica Forbici, Romina Salpini, Salvatore Dimonte, Stefano Alcaro, Francesca Ceccherini‐Silberstein, Carlo Federico Perno, (unknown)	5
19	Performance evaluation of the COBAS/TaqMan HIV-1 v2.0 in HIV-1 positive patients with low viral load: A comparative study 2011 ·Journal of Virological Methods ·Pierpaolo Paba, Lavinia Fabeni, Massimo Ciccozzi, Carlo Federico Perno, Marco Ciotti	18
20	Prevalence of resistance mutations related to integrase inhibitor S/GSK1349572 in HIV-1 subtype B raltegravir-naive and -treated patients 2011 ·Journal of Antimicrobial Chemotherapy ·Isabelle Malet, Marc Wirden, Slim Fourati, Daniele Armenia, Bernard Masquelier, Lavinia Fabeni, Sophie Sayon, Christine Katlama, Carlo Federico Perno, Vincent Cálvez, Anne‐Geneviève Marcelin, Francesca Ceccherini‐Silberstein	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact